In Venezuela, systemic analgesics are positioned as products for light and moderate pain and general discomfort. Acetaminophen is commonly positioned as appropriate to treat mild fever and often advertised as “safe” for dengue cases because other common analgesics, such as ibuprofen and aspirin, increase the severity of the symptoms when used for the haemorrhagic variant due to the potential for increased bleeding.
Adult acetaminophen exhibits the worst results in value terms due to larger volume losses in combination with low unit prices. A lower incidence of infectious diseases such as dengue fever, chikungunya fever and the zika virus, whose symptoms can be reduced only by the use of this analgesic, can also explain the disappointing performance.
Multinationals were no longer dominating analgesics in Venezuela in 2018. Two domestic companies, Laboratorios Ponce CA and Laboratorios Elmor, now lead analgesics, the former thanks to a clear dominance in topical analgesics/ anaesthetic with two important brands, Dencorub and Dencofen, thanks to the exit of Voltarén, manufactured by Novartis de Venezuela, which used to dominate topical analgesics/ anaesthetic.
Multinational companies occupy the third and fifth places in analgesics. Pfizer de Venezuela SA remains present with only one product, its bestselling product Atamel, which is the absolute leader in adult acetaminophen.
In adult combination products, Laboratorios Leti SA – a domestic company – holds an important share with its Migren brand, positioned towards the lessening of migraine symptoms, and also with Asaprol, its brand of aspirin that carries a very competitive price. Other competitors in aspirin include Laboratorios Oftalmi CA and Zuoz Pharma, with their brands Azacard and Cardipirina, respectively, positioned for heart health.
You have no recently viewed reports.
Why not browse through our Featured or Trending Reports to see what we have to offer?
Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Venezuela with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Analgesics industry in Venezuela, our research will save you time and money while empowering you to make informed, profitable decisions.
The Analgesics in Venezuela market research report includes:
Our market research reports answer questions such as:
Why buy this report?
This industry report originates from Passport, our Consumer Health market research database.